Key facts
- Notable investors include Geneva Private Equity (New York).
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for EKGenius
- ·The full record, as it builds
Funding rounds
No funding rounds for EKGenius are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About EKGenius
Manufacturer of a portable, stickerless 12-lead EKG platform intended to perform cardiac diagnostics across different care environments. The company offers FDA-cleared hardware, a digital software platform, and EMR and EHR integration, enabling hospitals, clinics, outpatient facilities, and decentralized care providers to record and manage cardiac data efficiently and accurately.
- Sector
- Healthcare
- HQ
- Long Island City, NY, United States
- Founded
- 2019
- Employees
- 2
- Website
- ekgenius.com/
- Ownership
- Privately Held (backing)
EKGenius doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in EKGenius shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on EKGenius in its N-PORT filings yet. We sweep new filings monthly.